Financial highlights Q3 2026

$2,693 million net sales, a decrease of 0.5%

1.1% organic sales decrease*

9.4% operating margin, 9.7% adj. operating margin*

$2.13 diluted EPS, a 6.8% decrease

Full year 2026 guidance

Around 0% organic sales growth

Around 2.5% positive FX impact on net sales

Around 10.5% adjusted operating margin

Around $1.2 billion operating cash flow

*For Non-GAAP measures see enclosed reconciliation tables.

(Dollars in millions, except per share data)

Q3 2026

Q3 2025

Change

9M 2026

9M 2025

Change

Net sales

$2,693

$2,706

(0.5)%

$8,249

$7,998

3.1%

Operating income

254

267

(5.0)%

683

769

(11)%

Adjusted operating income1)

262

271

(3.4)%

776

777

(0.1)%

Operating margin

9.4%

9.9%

(0.4)pp

8.3%

9.6%

(1.3)pp

Adjusted operating margin1)

9.7%

10.0%

(0.3)pp

9.4%

9.7%

(0.3)pp

Earnings per share - diluted

2.13

2.28

(6.8)%

5.36

6.59

(19)%

Adjusted earnings per share - diluted1)

2.19

2.32

(5.7)%

6.67

6.67

(0.1)%

Operating cash flow

239

258

(7.3)%

598

613

(2.5)%

Return on capital employed2)

24.1%

25.1%

(1.0)pp

21.5%

24.9%

(3.4)pp

Adjusted return on capital employed1,2)

24.4%

25.5%

(1.0)pp

24.2%

25.2%

(1.0)pp

Dividends paid

(63)

(65)

(2.7)%

(192)

(173)

11%

Share repurchases

(150)

(100)

50%

(350)

(201)

74%

1) Excluding effects from capacity alignments and antitrust related matters. Non-GAAP measure, see reconciliation table.
2) Annualized operating income and income from equity method investments, relative to average capital employed.

Comments from Mikael Bratt, President & CEO

We continued to deliver well across all key areas in the third quarter. Our sales in India grew by nearly 30% and our sales to Chinese OEMs grew by more than 20%. Strong sales growth in Japan contributed to our sales in Asia exceeding China in the quarter. Globally, our organic sales performance exceeded global LVP by around 1pp, significantly outpacing LVP growth in India, Japan and with Chinese OEMs.

To support our growing partnerships with Chinese OEMs, our innovation capabilities, global competitiveness and long term growth, we opened our second R&D center in China in Q3.

The business environment remains uncertain but we anticipate a strong fourth quarter supported by an increasing number of product launches and significant raw material recoveries.

Throughout the year, cost headwinds have increased materially, mainly related to raw materials, logistics, the recent flooding in Thailand and lower call off accuracy since Q1. We have been able to offset the majority of these cost headwinds mainly through labor efficiency, material savings through Value Engineering and successful negotiations with customers and suppliers. However, the additional headwinds narrows our full year adjusted operating margin expectation to around 10.5%, the low end of our range of around 10.5-11%. We continue to expect unchanged organic sales growth and an operating cash flow of around $1.2 billion.

Based on our full year guidance, we continue to expect strong cash flow for the year, which supports our ambition to provide attractive shareholder returns through share repurchases and dividends.

Finally, I would like to invite you to our 2027 Investor Day, which will take place in Shanghai, China, on April 26 and 27, 2027. It will be held in connection with the Auto Shanghai, the largest and most important auto show in the world.

We continued to successfully manage geopolitical developments during the quarter, limiting the effects of tariffs, supply chain challenges and raw material price increases. Well-executed cost reduction initiatives and increased engineering income contributed to a third quarter adjusted operating margin of 9.7%.

Our cash flow remained strong, supporting our ambitious shareholder return strategy. Our leverage ratio of 1.3x was almost unchanged compared with the prior quarter, despite repurchasing around 1.23 million shares for $150 million and paying dividends of $63 million in the quarter. Over the last 12 months, we have repurchased 4.14 million shares for $500 million, in addition to paying $258 million in dividends and keeping our debt leverage ratio unchanged.

Full year 2026 Guidance

Organic sales growth

Around 0%

Adjusted operating margin1)

Around 10.5%

Operating cash flow2)

Around $1.2 billion

Capex, net, % of sales

Around 4%

1) Excluding effects from capacity alignments, antitrust related matters and other discrete items. 2) Excluding unusual items.

Full year 2026 Assumptions

LVP growth

Around 2% negative

FX impact on net sales

Around 2.5% positive

Tax rate3)

Around 30%

3) Excluding unusual tax items.

Sales Development by region

Operating and adjusted* operating income and margins

Operating cash flow and capex, net

Shareholder returns

Return on Capital Employed

Cash Conversion*

Adj. operating income and margin*: Operating income adjusted for capacity alignments, antitrust related matters and for FY 2023 the Andrews litigation settlement. Capacity alignments include non-recurring costs related to our structural efficiency and business cycle management programs.

Capex, net: Capital Expenditure, net, defined as Expenditures for Property, Plant and Equipment less Proceeds from sale of Property, Plant and Equipment.

Cash conversion*: Free operating cash flow* in relation to net income. Free operating cash flow is defined as operating cash flow less capital expenditure, net.

Consolidated sales

Third quarter

Reported change

Currency

Organic

(Dollars in millions)

2026

2025

(U.S. GAAP)

effects1)

change*

Airbags, Steering Wheels and Other2)

$1,847

$1,830

0.9%

0.7%

0.2%

Seatbelt Products and Other2)

845

875

(3.5)%

0.5%

(3.9)%

Total

$2,693

$2,706

(0.5)%

0.6%

(1.1)%

Americas

$901

$897

0.4%

3.3%

(2.9)%

EMEA

711

745

(4.5)%

(1.6)%

(2.9)%

Asia excl. China

553

538

2.7%

(6.1)%

8.8%

China

528

526

0.4%

6.2%

(5.8)%

Total

$2,693

$2,706

(0.5)%

0.6%

(1.1)%

1) Effects from currency translations. 2) Including Corporate sales.

Sales by product – Airbags, Steering Wheels and Other

Sales for Airbags, Steering Wheels and Other grew organically* by 0.2% in the quarter. The largest contributors to the increase were side airbags, center airbags, driver airbags and steering wheels, partly offset by declines for passenger airbags, inflatable curtains and knee airbags.

Sales by product – Seatbelt Products and Other

Sales for Seatbelt Products and Other declined organically* by 3.9% in the quarter. Sales decreased organically in China, Americas and EMEA while they increased in Asia excluding China.

Sales by region

Our global organic sales* decreased by 1.1% compared to the global LVP decrease of 1.9% (according to Mobility Global, Oct 2026). The relative outperformance was positively impacted by product launches but negatively impacted by regional and model LVP mix development (around 90 bps). Our organic sales growth* outperformed LVP growth by 2.5pp in Asia excluding China and by 1.1pp in China. We underperformed LVP in EMEA by 3.7pp. Performance in the Americas overall was in line with LVP, while North America delivered stronger results, outperforming LVP by close to 2 percentage points.

LVP in China declined by 6.9%, with Global OEMs LVP declining by 25% and Chinese OEMs LVP growing by 1.4%. Autoliv's sales to domestic OEMs increased organically by around 21% while our sales to global OEMs decreased by around 29%. Chinese OEMs accounted for 58% of our sales in China in the quarter, compared to around 46% a year ago. We expect continued strong 2026 sales performance with domestic OEMs. Our strong sales growth in Asia excluding China was mainly due to 29% organic sales growth in India, reflecting strong LVP growth and the trend of increased safety content in vehicles in India.

Q3 2026 organic growth*

Americas

EMEA

Asia excl. China

China

Global

Autoliv

(2.9)%

(2.9)%

8.8%

(5.8)%

(1.1)%

Main growth drivers

Honda, Subaru, Toyota

Mercedes, JLR,
EV OEM

Suzuki, Indian OEM, Mazda

Chery, Geely, Great Wall

Mercedes, Chery, Suzuki

Main decline drivers

Ford, Stellantis,
EV OEM

VW, BMW, Stellantis

Subaru, Mitsubishi, Ford

Honda,VW, BMW

VW, Ford, Stellantis

Q3 2026

Americas

EMEA

Asia excl. China

China

Global

LVP (Oct 2026)

(3.0)%

0.8%

6.4 %

(6.9)%

(1.9)%

LVP (Jul 2026)

(2.2)%

(0.4)%

2.1%

(4.0)%

(2.1)%

Consolidated sales

First nine months

Reported change

Currency

Organic

(Dollars in millions)

2026

2025

(U.S. GAAP)

effects1)

change*

Airbags, Steering Wheels and Other2)

$5,617

$5,395

4.1%

2.8%

1.3%

Seatbelt Products and Other2)

2,632

2,603

1.1%

3.1%

(2.0)%

Total

$8,249

$7,998

3.1%

2.9%

0.2%

Americas

$2,673

$2,639

1.3%

5.1%

(3.8)%

EMEA

2,378

2,337

1.8%

4.1%

(2.3)%

Asia excl. China

1,655

1,572

5.3%

(5.1)%

10%

China

1,542

1,450

6.4%

5.9%

0.5%

Total

$8,249

$7,998

3.1%

2.9%

0.2%

1) Effects from currency translations. 2) Including Corporate sales.

Sales by product – Airbags, Steering Wheels and Other

Sales for Airbags, Steering Wheels and Other grew organically* by 1.3% in the period. The largest contributors to the increase were side airbags and center airbags, followed by driver airbags, partly offset by declines for passenger airbags, steering wheels and inflatable curtains.

Sales by product – Seatbelt Products and Other

Sales for Seatbelt Products and Other declined organically* by 2.0% in the period. Sales decreased organically in Americas, China and EMEA while they increased in Asia excluding China.

Sales by region

Our global organic sales* increased by 0.2% compared to the global LVP decrease of 0.9% (according to Mobility Global, Oct 2026). The relative outperformance was mainly driven by new product launches. Our organic sales growth outperformed LVP growth by 6.9pp in China and by 4.3pp in Asia excluding China. We underperformed LVP in EMEA by 3.7pp and by 3.5pp in Americas, impacted mainly by negative mix due to high LVP growth in lower content South America and a lower content on some replacement models.

LVP in China declined by 6.3%, with Global OEMs LVP declining by 16% and Chinese OEMs LVP decreased by 1.6%. Autoliv's sales to domestic OEMs increased organically by around 31% while our sales to global OEMs decreased by around 21%. Chinese OEMs accounted for 53% of our sales in China in the first nine months of 2026, compared to 41% a year ago. Our strong sales growth in Asia excluding China was mainly due to 34% organic sales growth in India, reflecting strong LVP growth but mainly the trend of increased safety content in vehicles in India.

9M 2026 organic growth*

Americas

EMEA

Asia excl. China

China

Global

Autoliv

(3.8)%

(2.3)%

10%

0.5%

0.2%

Main growth drivers

Subaru, Honda, Stellantis

Mercedes, EV OEM, Renault

Suzuki, Indian OEM, Mazda

Chery, Nio, Geely

Suzuki, Chery, Nio

Main decline drivers

Ford, Hyundai,
EV OEM

VW, Stellantis, BMW

Subaru, Ford, Mitsubishi

VW, Honda, Mercedes

VW, Ford, BMW

First nine months 2026

Americas

EMEA

Asia excl. China

China

Global

LVP (Oct 2026)

(0.2)%

1.4%

6.1 %

(6.3)%

(0.9)%

LVP (Jan 2026)

(1.1)%

(0.9)%

1.9%

(1.4)%

(0.6)%

Condensed Income Statement

Third quarter

First nine months

(Dollars in millions, except per share data)

2026

2025

Change

2026

2025

Change

Net sales

$2,693

$2,706

(0.5)%

$8,249

$7,998

3.1%

Cost of sales

(2,197)

(2,184)

0.6%

(6,717)

(6,496)

3.4%

Gross profit

496

522

(5.0)%

1,531

1,502

2.0%

S,G&A

(138)

(137)

0.9%

(437)

(427)

2.4%

R,D&E, net

(99)

(117)

(16)%

(341)

(319)

6.8%

Other income (expense), net

(5)

(1)

559%

(70)

13

n/a

Operating income

254

267

(5.0)%

683

769

(11)%

Adjusted operating income1)

262

271

(3.4)%

776

777

(0.1)%

Financial and non-operating items, net

(24)

(27)

(13)%

(97)

(76)

28%

Income before taxes

230

240

(4.0)%

586

693

(15)%

Income taxes

(75)

(65)

16%

(188)

(183)

3.0%

Net income

$155

$175

(11)%

$398

$510

(22)%

Earnings per share - diluted2)

$2.13

$2.28

(6.8)%

$5.36

$6.59

(19)%

Adjusted earnings per share - diluted1,2)

$2.19

$2.32

(5.7)%

$6.67

$6.67

(0.1)%

Gross margin

18.4%

19.3%

(0.9)pp

18.6%

18.8%

(0.2)pp

S,G&A, in relation to sales

(5.1)%

(5.1)%

(0.1)pp

(5.3)%

(5.3)%

0.0pp

R,D&E, net in relation to sales

(3.7)%

(4.3)%

0.7pp

(4.1)%

(4.0)%

(0.1)pp

Operating margin

9.4%

9.9%

(0.4)pp

8.3%

9.6%

(1.3)pp

Adjusted operating margin1)

9.7%

10.0%

(0.3)pp

9.4%

9.7%

(0.3)pp

Tax Rate

32.5%

26.9%

5.6pp

32.2%

26.4%

5.8pp

Other data

No. of shares at period-end in millions2)

72.0

76.0

(5.2)%

72.0

76.0

(5.2)%

Weighted average no. of shares in millions, basic2)

72.6

76.4

(4.9)%

73.8

77.0

(4.1)%

Weighted average no. of shares in millions, diluted2)

72.9

76.7

(5.0)%

74.1

77.3

(4.2)%

1) Non-GAAP measure, excluding effects from capacity alignments and antitrust related matters. See reconciliation table. 2) Net of treasury shares.

Third quarter 2026 development

Gross profit decreased by $26 million, and gross margin decreased by 0.9pp compared to the prior year. The decrease in gross profit was mainly attributable to the $13 million gross profit impact of the supplier settlement compensation reported in Q3 2025, lower net sales and higher logistics costs.

S,G&A costs increased by $1 million compared to the prior year, mainly due to slightly higher IT expenses and professional services costs partly offset by slightly lower personnel costs. S,G&A costs in relation to sales were unchanged at 5.1%.

R,D&E, net, costs decreased by $18 million compared to the prior year, mainly due to $26 million of higher engineering income related to timing effects, partly offset by adverse effects from FX translation, IT expenses and personnel costs. R,D&E, net, in relation to sales decreased from 4.3% to 3.7%.

Other income (expense), net, was negative $5 million, compared to negative $1 million in the same period last year. The negative $5 million in Q3 2026 consisted mainly of capacity alignment costs related to our restructuring activities in Türkiye.

Operating income decreased by $13 million compared to the prior year, mainly due to lower gross profit and higher capacity alignment costs, partly offset by lower R,D&E, net, costs, as outlined above.

Adjusted operating income* decreased by $9 million compared to the prior year, mainly due to the lower gross profit, partly offset by lower R,D&E, net, costs, as outlined above.

Financial and non-operating items, net, was a negative $24 million compared to a negative $27 million a year earlier. The improvement was mainly due to lower costs for non-operating items mainly related to positive FX effects.

Income before taxes decreased by $10 million compared to the prior year, mainly due to lower operating income, partly offset by lower costs for financial and non-operating items, net, as outlined above.

Tax rate was 32.5% compared to 26.9% in the prior year. Discrete tax items, net, had an unfavorable impact of 4.9pp in Q3 2026, while discrete tax items, net, had a favorable impact of 1.3pp in Q3 2025. Discrete tax items recorded in Q3 2026 primarily related to negative tax impacts from the closure of tax audits during the quarter.

Earnings per share, diluted decreased by $0.15 compared to the prior year. The main drivers were negative impacts of $0.16 from higher taxes and $0.13 from lower operating income partly offset by $0.11 from a lower number of outstanding shares, diluted and $0.05 from lower financial and non-operating items.

First nine months 2026 development

Gross profit increased by $30 million while gross margin decreased by 0.2pp compared to the prior year. The drivers behind the gross profit improvement were mainly positive effects of higher sales and positive FX translation effects. This was partly offset by $25 million impact from a supplier compensation booked in Q3 2025 which was reversed in Q2 2026, and asset impairment related to the restructuring activities in Türkiye.

S,G&A costs increased by $10 million compared to the prior year, mainly due to negative FX translation effects and higher personnel costs, partly offset by the revision of an estimated credit loss reserve. S,G&A costs in relation to sales were unchanged at 5.3%.

R,D&E, net, costs increased by $22 million compared to the prior year, mainly due to higher personnel costs and negative FX translation effects, partly offset by higher engineering income. R,D&E, net, in relation to sales increased from 4.0% to 4.1%.

Other income (expense), net, was negative $70 million, compared to positive $13 million in the same period last year. The increase in costs was mainly due to higher capacity alignment costs related to restructuring activities in Türkiye.

Operating income decreased by $86 million compared to the prior year, mainly due to higher capacity alignment costs related to restructuring activities in Türkiye, higher R,D&E, net, costs and higher S,G&A costs, partly offset by higher gross profit as outlined above.

Adjusted operating income* decreased by $1 million compared to the prior year, due to the higher costs for R,D&E, net and S,G&A offset by the higher gross profit, as outlined above.

Financial and non-operating items, net, was negative $97 million compared to negative $76 million a year earlier. The increase in costs was mainly due to higher non-operating items, mainly related to costs associated with restructuring activities in Türkiye and Mexico.

Income before taxes decreased by $107 million compared to the prior year, mainly due to lower operating income and higher costs for financial and non-operating items, net, as outlined above.

Tax rate was 32.2% compared to 26.4% in the prior year. Discrete tax items, net, for the period had an unfavorable impact of 4.2pp. Discrete tax items, net, for the prior year period had a favorable impact of 1.8pp. Discrete tax items recorded in the first nine months of 2026 primarily related to negative tax impacts from closure of tax audits during the third quarter and negative tax impacts recorded in the first half year from costs recorded for the capacity alignment activities for Autoliv’s manufacturing operations in Türkiye.

Earnings per share, diluted decreased by $1.23 compared to the prior year. The main drivers were negative impacts of $0.82 from lower operating income, $0.43 from higher tax and $0.18 from financial and non-operating items, partly offset by $0.22 from a lower number of outstanding shares, diluted.

Selected Cash Flow items

Third quarter

First nine months

(Dollars in millions)

2026

2025

Change

2026

2025

Change

Net income

$155

$175

(11)%

$398

$510

(22)%

Depreciation and amortization

107

103

3.1%

328

299

10%

Other non-cash adjustments, net

22

32

(30)%

26

20

26%

Changes in operating working capital

(45)

(53)

(15)%

(154)

(217)

(29)%

Operating cash flow

239

258

(7.3)%

598

613

(2.5)%

Capital expenditure, net1)

(115)

(106)

8.7%

(293)

(313)

(6.4)%

Free operating cash flow2)

$124

$153

(18)%

$305

$300

1.7%

Cash conversion3)

80%

87%

(6.9)pp

77%

59%

18pp

Shareholder returns

- Dividends paid

(63)

(65)

(2.7)%

(192)

(173)

11%

- Share repurchases

(150)

(100)

50%

(350)

(201)

74%

Cash dividend paid per share

$(0.87)

$(0.85)

2.6%

$(2.61)

$(2.25)

16%

Capital expenditures, net in relation to sales

4.3%

3.9%

0.4pp

3.6%

3.9%

(0.3)pp

1) Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. 2) Operating cash flow less Capital expenditure, net. Non-GAAP measure. See enclosed reconciliation table. 3) Free operating cash flow relative to Net income. Non-GAAP measure. See reconciliation table.

Selected Balance Sheet items

Third quarter

(Dollars in millions)

2026

2025

Change

Trade working capital1)

$1,451

$1,504

(3.6)%

Trade working capital in relation to sales2)

13.5%

13.9%

(0.4)pp

- Receivables outstanding in relation to sales3)

22.5%

21.8%

0.7pp

- Inventory outstanding in relation to sales4)

9.5%

9.6%

(0.1)pp

- Payables outstanding in relation to sales5)

18.5%

17.5%

1.0pp

Cash & cash equivalents

197

225

(12)%

Gross Debt6)

1,934

2,027

(4.6)%

Net Debt7)

1,763

1,772

(0.5)%

Capital employed8)

4,233

4,331

(2.3)%

Return on capital employed9)

24.1%

25.1%

(1.0)pp

Total equity

2,470

2,559

(3.5)%

Return on total equity10)

25.0%

27.9%

(2.8)pp

Leverage ratio11)

1.3

1.3

(0.0)

1) Outstanding receivables and outstanding inventory less outstanding payables. Non-GAAP measure, see reconciliation table. 2) Outstanding receivables and outstanding inventory less outstanding payables relative to annualized quarterly sales. Non-GAAP measure, see reconciliation table. Annualized quarterly sales is calculated as the quarterly sales amount multiplied by four. 3) Outstanding receivables relative to annualized quarterly sales. 4) Outstanding inventory relative to annualized quarterly sales. 5) Outstanding payables relative to annualized quarterly sales. 6) Short- and long-term interest-bearing debt. 7) Short- and long-term debt less cash and cash equivalents and debt-related derivatives. Non-GAAP measure. See reconciliation table. 8) Total equity and net debt. 9) Annualized operating income and income from equity method investments, relative to average capital employed. See definitions of "Annualized operating income" in footnote to the reconciliation tables below. 10) Annualized net income relative to average total equity. See definitions of "Annualized net income" in footnote to the reconciliation tables below. 11) Net debt adjusted for pension liabilities in relation to EBITDA. Non-GAAP measure. See reconciliation table.

Third quarter 2026 development

Changes in operating working capital had a $45 million negative impact on operating cash flow compared to a negative impact of $53 million in the prior year. The $45 million increase in operating working capital resulted mainly from $71 million in higher inventories and $21 million from receivables, net, partly offset by $52 million from accounts payable and accrued liabilities.

Operating cash flow decreased by $19 million to $239 million compared to the prior year, mainly because of lower net income, partly offset by a smaller increase in operating working capital compared to last year.

Capital expenditure, net, increased by $9 million compared to the prior year. The level of capital expenditure, net, in relation to sales increased to 4.3% versus 3.9% a year earlier.

Free operating cash flow* was positive $124 million compared to positive $153 million in the prior year. The decrease was due to lower operating cash flow and higher capital expenditure, net, as outlined above.

Cash conversion* defined as free operating cash flow* in relation to net income, was 80% compared to 87% a year earlier.

Trade working capital* in relation to sales decreased from 13.9% to 13.5%. The improvement was mainly driven by higher payables in relation to sales while inventories and receivables to sales were relatively unchanged.

Net debt* was $1,763 million as of September 30, 2026, which was $9 million lower than a year earlier.

Total equity as of September 30, 2026, decreased by $89 million compared to September 30, 2025. This was mainly due to $505 million in share repurchases, including taxes, and $258 million in dividend payments, partly offset by net income of $623 million.

Leverage ratio*: On September 30, 2026, the Company had a leverage ratio of 1.3x compared to 1.3x on September 30, 2025, as the 12 months trailing adjusted EBITDA* increased by $26 million while net debt* per the policy decreased by $1 million. Our target is to have a leverage ratio not higher than 1.5x.

First nine months 2026 development

Operating cash flow decreased by $15 million to $598 million compared to the prior year, mainly because the lower net income was almost offset by a smaller increase in working capital and higher depreciation.

Capital expenditure, net, decreased by $20 million compared to the prior year. The level of capital expenditure, net, in relation to sales was 3.6% versus 3.9% a year earlier.

Free operating cash flow* was positive $305 million compared to positive $300 million in the prior year. The increase was mainly due to the lower level of capital expenditure, net.

Cash conversion* defined as free operating cash flow* in relation to net income, was 77% compared to 59% a year earlier as free operating cash flow increased while net income decreased.

Sep 30

Jun 30

Sep 30

2026

2026

2025

Total headcount

64,400

63,500

65,200

Whereof: Direct headcount in manufacturing

47,000

46,200

47,900

                 Indirect headcount

17,400

17,300

17,300

Temporary personnel

13%

11%

9%

As of September 30, 2026, total headcount (Full Time Equivalent) decreased by around 800, or 1.3%, compared to a year earlier. The indirect workforce increased by around 100, or 0.6%. The direct workforce decreased by approximately 1,000, or 2.0%, reflecting continued good productivity development.

Compared to June 30, 2026, total headcount (Full Time Equivalent) increased by around 900, or 1.4%. Indirect headcount increased by around 100, while direct headcount increased by approximately 800.

Next Report

Autoliv intends to publish the quarterly earnings report for the fourth quarter of 2026 on Friday, January 29, 2027.

Footnotes

*Non-GAAP measures, see enclosed reconciliation tables.

Inquiries: Investors and Analysts

Anders Trapp

Vice President Investor Relations

Tel +46 (0)709 578 171

Henrik Kaar

Director Investor Relations

Tel +46 (0)709 578 114

Inquiries: Media

Gabriella Etemad

Senior Vice President Communications

Tel +46 (0)70 612 6424

Autoliv, Inc. is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the VP of Investor Relations set out above, at 12.00 CEST on October 23, 2026.

Definitions and SEC Filings

Please refer to www.autoliv.com or to our Annual Report for definitions of terms used in this report. Autoliv’s annual report to stockholders, annual report on Form 10-K, quarterly reports on Form 10-Q, proxy statements, management certifications, press releases, current reports on Form 8-K and other documents filed with the SEC can be obtained free of charge from Autoliv at the Company’s address. These documents are also available on the SEC’s website www.sec.gov and on Autoliv’s corporate website www.autoliv.com.

This report includes content supplied by Mobility Global; Copyright © Light Vehicle Production Forecast, January, July and October 2026. All rights reserved. Mobility Global is a global supplier of independent industry information. The permission to use Mobility Global copyrighted reports, data and information does not constitute an endorsement or approval by Mobility Global of the manner, format, context, content, conclusion, opinion or viewpoint in which Mobility Global reports, data and information or its derivations are used or referenced herein.

This report contains statements that are not historical facts but rather forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include those that address activities, events or developments that Autoliv, Inc. or its management believes or anticipates may occur in the future. All forward-looking statements are based upon our current expectations, various assumptions and/or data available from third parties. Our expectations and assumptions are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that such forward-looking statements will materialize or prove to be correct as forward-looking statements are inherently subject to known and unknown risks, uncertainties and other factors which may cause actual future results, performance or achievements to differ materially from the future results, performance or achievements expressed in or implied by such forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “estimates”, “expects”, “anticipates”, “projects”, “plans”, “intends”, “believes”, “may”, “likely”, “might”, “would”, “should”, “could”, or the negative of these terms and other comparable terminology, although not all forward-looking statements contain such words. Because these forward-looking statements involve risks and uncertainties, the outcome could differ materially from those set out in the forward-looking statements for a variety of reasons, including without limitation: general global and regional economic conditions, including the impact of inflation; changes in light vehicle production; fluctuation in vehicle production schedules for which the Company is a supplier; global supply chain disruptions, including port, transportation, and distribution delays or interruptions; supply chain disruptions, and component shortages specific to the automotive industry or the Company; potential changes to beneficial free trade agreements and regulations, such as the United States-Mexico-Canada Agreement; changes in geopolitical and other economic and political conditions or developments, including inflation, changes trade policies, tariff regimes, and other developments in and by countries in which we do business that could materially impact supply chains, margins, access to capital, or overall business performance; political stability or geopolitical conflicts; changes in general industry or market conditions, including regional economic growth or decline; changes in and the successful execution of our capacity alignment, restructuring, cost reduction, and efficiency initiatives and the market reaction thereto; loss of business from increased competition; volatility or increases in raw material, fuel, and energy costs, changes in consumer and customer preferences for end products; loss of customers or sales; legislative or regulatory changes; customer bankruptcies, consolidations or restructuring or divestiture of customer brands; unfavorable fluctuations in currencies or interest rates among the various jurisdictions in which we operate; market acceptance of our new products; costs or difficulties related to the integration of any new or acquired businesses and technologies; continued uncertainty in pricing and other negotiations with

customers, including inflation and tariff compensations; successful integration of acquisitions and operations of joint ventures; successful implementation of strategic partnerships and collaborations; our ability to be awarded new business; product liability, warranty and recall claims and investigations and other litigation, civil judgments or financial penalties and customer reactions thereto; higher expenses for our pension and other postretirement benefits, including higher funding needs for our pension plans; work stoppages or other labor issues; possible adverse results of pending or future litigation or infringement claims, and the availability of insurance with respect to such matters; our ability to protect our intellectual property rights; negative impacts of antitrust investigations or other governmental investigations and associated litigation relating to the conduct of our business; tax assessments or results of tax audits by governmental authorities and changes in our effective tax rate; dependence on key personnel; our ability to meet our sustainability targets, goals and commitments; dependence on and relationships with customers and suppliers; the conditions necessary to hit our financial targets; and other risks and uncertainties identified under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Reports and Quarterly Reports on Forms 10-K and 10-Q and any amendments thereto. For any forward-looking statements contained in this or any other document, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we assume no obligation to update publicly or revise any forward-looking statements in light of new information or future events, except as required by law.

Third quarter

First nine months

Latest 12

Full Year

(Dollars in millions, except per share data, unaudited)

2026

2025

2026

2025

months

2025

Airbags, Steering Wheels and Other1)

$1,847

$1,830

$5,617

$5,395

$7,524

$7,302

Seatbelt products and Other1)

845

875

2,632

2,603

3,542

3,513

Total net sales

2,693

2,706

8,249

7,998

11,066

10,815

Cost of sales

(2,197)

(2,184)

(6,717)

(6,496)

(8,963)

(8,741)

Gross profit

496

522

1,531

1,502

2,104

2,074

Selling, general & administrative expenses

(138)

(137)

(437)

(427)

(581)

(571)

Research, development & engineering expenses, net

(99)

(117)

(341)

(319)

(435)

(413)

Other income (expense), net

(5)

(1)

(70)

13

(85)

(2)

Operating income

254

267

683

769

1,003

1,088

Income from equity method investments

0

2

2

4

4

6

Interest income

2

3

7

7

10

10

Interest expense

(23)

(25)

(76)

(77)

(102)

(103)

Other non-operating items, net

(2)

(7)

(30)

(10)

(35)

(15)

Income before income taxes

230

240

586

693

879

986

Income taxes

(75)

(65)

(188)

(183)

(256)

(250)

Net income

155

175

398

510

623

736

Less: Net income attributable to non-controlling interest

0

0

1

1

1

1

Net income attributable to controlling interest

$155

$175

$397

$509

$622

$735

Earnings per share - diluted

$2.13

$2.28

$5.36

$6.59

$8.36

$9.55

1) Including Corporate sales.

Sep 30

Jun 30

Mar 31

Dec 31

Sep 30

(Dollars in millions, unaudited)

2026

2026

2026

2025

2025

Assets

Cash & cash equivalents

$197

$377

$342

$604

$225

Receivables, net

2,422

2,387

2,422

2,236

2,357

Inventories, net

1,020

945

947

992

1,036

Prepaid expenses

229

224

206

212

226

Other current assets

83

76

71

57

102

Total current assets

3,951

4,009

3,987

4,101

3,946

Property, plant & equipment, net

2,349

2,340

2,356

2,417

2,402

Operating leases right-of-use assets

159

157

166

171

167

Goodwill and intangible assets, net

1,398

1,394

1,392

1,386

1,387

Investments and other non-current assets

571

597

567

568

561

Total assets

8,427

8,497

8,468

8,644

8,463

Liabilities and equity

Short-term debt

251

350

393

419

654

Accounts payable

1,990

1,982

1,862

2,007

1,889

Accrued liabilities

1,189

1,130

1,024

1,050

1,172

Operating lease liabilities - current

41

41

43

43

44

Other current liabilities

387

394

386

404

383

Total current liabilities

3,859

3,897

3,708

3,923

4,141

Long-term debt

1,683

1,688

1,699

1,734

1,374

Pension liability

175

180

176

169

167

Operating lease liabilities - non-current

113

110

117

122

118

Other non-current liabilities

127

122

125

113

105

Total non-current liabilities

2,098

2,099

2,115

2,138

1,763

Total parent shareholders’ equity

2,459

2,490

2,634

2,572

2,549

Non-controlling interest

11

11

10

10

10

Total equity

2,470

2,501

2,644

2,582

2,559

Total liabilities and equity

$8,427

$8,497

$8,468

$8,644

$8,463

Third quarter

First nine months

Latest 12

Full Year

(Dollars in millions, unaudited)

2026

2025

2026

2025

months

2025

Net income

$155

$175

$398

$510

$623

$736

Depreciation and amortization

107

103

328

299

437

407

Gain on divestiture of property

-

-

-

(6)

(0)

(6)

Other non-cash adjustments, net

22

32

26

26

31

32

Net change in operating working capital:

   Receivables

(23)

(4)

(128)

(170)

(55)

(98)

   Other current assets

3

12

(73)

(122)

24

(26)

   Inventories

(71)

(78)

(39)

(52)

5

(8)

   Accounts payable

(1)

(57)

(24)

10

84

119

   Accrued liabilities

53

82

129

107

(7)

(30)

   Income taxes

(5)

(9)

(19)

11

0

30

Net cash provided by operating activities

239

258

598

613

1,142

1,157

Expenditures for property, plant and equipment

(115)

(106)

(295)

(323)

(413)

(441)

Proceeds from sale of property, plant and equipment

1

1

2

10

10

18

Acquisition of interest in Affiliates

(0)

-

(2)

-

(2)

-

Net cash used in investing activities

(115)

(106)

(295)

(313)

(405)

(423)

Net (decrease) increase in short term debt

(99)

(26)

117

247

(120)

11

Decrease in long-term debt

-

-

(285)

(311)

(285)

(311)

Increase in long-term debt

10

46

2

122

401

521

Dividends paid

(63)

(65)

(192)

(173)

(258)

(238)

Share repurchases

(150)

(100)

(350)

(201)

(500)

(351)

Common stock options exercised

-

-

-

0

-

0

Dividend paid to non-controlling interests

(0)

(1)

(0)

(1)

(0)

(1)

Net cash used in financing activities

(302)

(146)

(709)

(316)

(762)

(369)

Effect of exchange rate changes on cash

(2)

(18)

(1)

(89)

(2)

(90)

(Decrease) increase in cash and cash equivalents

(180)

(12)

(407)

(105)

(28)

274

Cash and cash equivalents at period-start

377

237

604

330

225

330

Cash and cash equivalents at period-end

$197

$225

$197

$225

$197

$604

Sep 30

Jun 30

Mar 31

Dec 31

Sep 30

(Dollars in millions)

2026

2026

2026

2025

2025

Total current assets

$3,951

$4,009

$3,987

$4,101

$3,946

Total current liabilities

(3,859)

(3,897)

(3,708)

(3,923)

(4,141)

Working capital (GAAP)

92

113

278

178

(195)

Less: Cash and cash equivalents

(197)

(377)

(342)

(604)

(225)

          Prepaid expenses

(229)

(224)

(206)

(212)

(226)

          Other current assets

(83)

(76)

(71)

(57)

(102)

Less: Short-term debt

251

350

393

419

654

          Accrued liabilities

1,189

1,130

1,024

1,050

1,172

          Operating lease liabilities - current

41

41

43

43

44

          Other current liabilities

387

394

386

404

383

Trade working capital (Non-GAAP)

$1,451

$1,350

$1,506

$1,221

$1,504

Sep 30

Jun 30

Mar 31

Dec 31

Sep 30

(Dollars in millions)

2026

2026

2026

2025

2025

Receivables, net

$2,422

$2,387

$2,422

$2,236

$2,357

Inventories, net

1,020

945

947

992

1,036

Accounts payable

(1,990)

(1,982)

(1,862)

(2,007)

(1,889)

Trade working capital (Non-GAAP)

$1,451

$1,350

$1,506

$1,221

$1,504

Quarterly sales

$2,693

$2,803

$2,753

$2,817

$2,706

Annualized quarterly sales1)

10,770

11,213

11,012

11,269

10,822

Trade working capital (Non-GAAP) in relation to annualized quarterly sales

13.5%

12.0%

13.7%

10.8%

13.9%

1) Calculated as the current quarterly sales multiplied by four.

Dec 31

Dec 31

Dec 31

Dec 31

(Dollars in millions)

2024

2023

2022

2021

Total current assets

$3,483

$3,974

$3,714

$3,675

Total current liabilities

(3,633)

(4,035)

(3,642)

(2,821)

Working capital (GAAP)

(150)

(61)

72

853

Less: Cash and cash equivalents

(330)

(498)

(594)

(969)

          Prepaid expenses

(167)

(173)

(160)

(164)

          Other current assets

(72)

(93)

(84)

(65)

Less: Short-term debt

387

538

711

346

          Accrued liabilities

1,056

1,135

915

996

          Operating lease liabilities - current

41

39

39

38

          Other current liabilities

351

345

283

297

Trade working capital (Non-GAAP)

$1,115

$1,232

$1,183

$1,332

Dec 31

Dec 31

Dec 31

Dec 31

(Dollars in millions)

2024

2023

2022

2021

Receivables, net

$1,993

$2,198

$1,907

$1,699

Inventories, net

921

1,012

969

777

Accounts payable

(1,799)

(1,978)

(1,693)

(1,144)

Trade working capital (Non-GAAP)

$1,115

$1,232

$1,183

$1,332

Quarterly sales

$2,616

$2,751

$2,335

$2,119

Annualized quarterly sales1)

10,463

11,006

9,340

8,476

Trade working capital (Non-GAAP) in relation to annualized quarterly sales

10.7%

11.2%

12.7%

15.7%

1) Calculated as the fourth quarterly sales multiplied by four.

Sep 30

Jun 30

Mar 31

Dec 31

Sep 30

(Dollars in millions)

2026

2026

2026

2025

2025

Short-term debt

$251

$350

$393

$419

$654

Long-term debt

1,683

1,688

1,699

1,734

1,374

Total debt (GAAP)

1,934

2,037

2,091

2,153

2,027

Cash & cash equivalents

(197)

(377)

(342)

(604)

(225)

Debt issuance cost/Debt-related derivatives, net

26

34

23

17

(30)

Net debt (Non-GAAP)

$1,763

$1,695

$1,773

$1,566

$1,772

Dec 31

Dec 31

Dec 31

Dec 31

(Dollars in millions)

2024

2023

2022

2021

Short-term debt

$387

$538

$711

$346

Long-term debt

1,522

1,324

1,054

1,662

Total debt (GAAP)

1,909

1,862

1,766

2,008

Cash & cash equivalents

(330)

(498)

(594)

(969)

Debt issuance cost/Debt-related derivatives, net

(24)

3

12

13

Net debt (Non-GAAP)

$1,554

$1,367

$1,184

$1,052

Sep 30

Jun 30

Sep 30

(Dollars in millions)

2026

2026

2025

Net debt1) (Non-GAAP)

$1,763

$1,695

$1,772

Pension liabilities

175

180

167

Net debt per the Policy (Non-GAAP)

$1,938

$1,874

$1,939

Net income2)

$623

$643

$754

Income taxes2)

256

246

261

Interest expense, net2, 3)

92

93

94

Other non-operating items, net2)

35

40

20

Income from equity method investments2)

(4)

(5)

(6)

Depreciation and amortization of intangibles2)

437

434

397

Capacity alignments2)

110

104

(1)

Antitrust related items2)

1

2

5

Other items2)

-

-

-

EBITDA per the Policy (Adjusted EBITDA) (Non-GAAP)

$1,550

$1,556

$1,524

Leverage ratio (Non-GAAP)

1.3

1.2

1.3

1) Short- and long-term debt less cash and cash equivalents and debt-related derivatives. 2) Latest 12 months. 3) Interest expense, including cost for extinguishment of debt, if any, less interest income.

Third quarter

First nine months

Latest 12

Full Year

(Dollars in millions)

2026

2025

2026

2025

months

2025

Net income

$155

$175

$398

$510

$623

$736

Depreciation and amortization

107

103

328

299

437

407

Gain on divestiture of property

-

-

-

(6)

(0)

(6)

Other, net

22

32

26

26

31

32

Changes in operating working capital, net

(45)

(53)

(154)

(217)

51

(12)

Operating cash flow (GAAP)

239

258

598

613

1,142

1,157

Expenditures for property, plant and equipment

(115)

(106)

(295)

(323)

(413)

(441)

Proceeds from sale of property, plant and equipment

1

1

2

10

10

18

Capital expenditure, net1)

(115)

(106)

(293)

(313)

(403)

(423)

Free operating cash flow2) (Non-GAAP)

$124

$153

$305

$300

$739

$734

Cash conversion3) (Non-GAAP)

80%

87%

77%

59%

119%

100%

1) Defined as Expenditures for property, plant and equipment less Proceeds from sale of property, plant and equipment. 2) Operating cash flow less Capital expenditure, net.
3) Free operating cash flow relative to Net income.

Full year

Full year

Full year

Full year

(Dollars in millions)

2024

2023

2022

2021

Net income

$648

$489

$425

$437

Depreciation and amortization

387

378

363

394

Gain on divestiture of property

(4)

-

(80)

-

Other, net

(24)

(119)

(54)

(15)

Changes in operating working capital, net

53

235

58